Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains

Neurobiology of Aging

Volumn 18, Issue 1, 1997, Pages 121-127

  Pirttila T ^a,b   Soininen, H ^c   Mehta, P D ^a   Heinonen, O ^c   Lehtimaki T ^b   Bogdanovic, N ^d   Paljarvi L ^c   Kim, K S ^a   Kosunen, O ^c   Winblad, B ^d   Riekkinen Sr , P ^c   Wisniewski, H M ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer disease; amyloid; apolipoprotein E; brain extracts

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; FRONTAL CORTEX; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; BRAIN CHEMISTRY; CEREBELLAR CORTEX; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLES; SEX CHARACTERISTICS;

EID: 0031046146     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(96)00204-7     Document Type: Article

References (47)

1. Alafuzoff, I.; Iqbal, K.; Friden, H.; Adolfsson, R.; Winblad, B. Histopathological criteria for progressive dementia disorders: Clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol. 74:209-225; 1987.
2. Arriagada, P. V.; Growdon, J. H.; Hedley-Whyte, E. T.; Hyman B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42:631-639; 1992.
3. Barrow, C. J.; Yasuda, A.; Kenny, P. T. M.; Zagorski, M. G. Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. J. Mol. Biol. 225:1075-1093; 1992.
4. Bierer, L. M.; Hof, P. R.; Purohit, D. P.; Carlin, L.; Schmeidler, J.; Davis, K. L., Perl, D. P. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch. Neurol. 52:81-88; 1995.
5. Corder, E. H.,; Saunders, A. M.; Strittmatter, W. J.; Schmechel, D. E.; Gaskell, P.C.; Small, G. W.; Roses, A.D.; Haines, J. L.; PericakVance, M. A. Gene duse of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923; 1993.
6. Davies, C. A.; Mann, D. M. A. Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar? Am. J. Pathol. 143:1594-1605; 1993.
7. Delaere, P.; He, Y.; Fayet, G.; Duyckaerts, C.; Hauw, J. J. βA4 deposits are constant in the brain of the oldest old: An immunocyto-chemical study of 20 French centenarians. Neurobiol. Aging 14:191-194; 1993.
8. Dickson, D. W.; Crystal, H. A.; Mattiace, L. A.; Masur, D. M.; Blau, A. D.; Davies, P.; Yen, S. H.; Aronson M. K. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 13:179-189; 1991.
9. Gowing, E.; Roher, A. E., Woods, A. S.; Cotter, R. J.; Chaney, M.; Little, S. P.; Ball, M. J. Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J. Biol. Chem. 269:10987-10990; 1994.
10. Haass, C.; Schlossmacher, M, G.; Hung, A.-Y.; Vigo-Pelfrey, C.; Mellon, A.; Ostaszewski, B. L.; Lieberburg, I.; Koo, E. H.; Schenk, D.; Teplow, D. B.; Selkoc, D. J. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322-326; 1992.
11. Heinonen, O.; Soininen, H.; Sorvari, H.; Kosunen, O.; Paljärvi, L.; Koivisto, E.; Riekkinen, P. J. Sr. Loss of synaptophysin-like immuno-reactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience 64:375-384; 1995.
12. Hixson, J. E.; Vernier, D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J. Lipid Res. 31:545-548; 1990.
13. Iwatsubo, T.; Odaka, A.; Suzuki, N.; Mizusawa, H.; Nukina, N.; Ihara, Y. Visualization of Aβ42/43 and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42/43. Neuron 13:45-53; 1994.
14. Joachim, C. L.; Morris, J. H.; Selkoe, D. J. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am. J. Pathol. 135:309-319; 1989.
15. Kim, K. S.; Wen, G. Y.; Bancher, C.; Chen, C. M. J.; Sapienza, V. J.; Hong, H.; Wisniewski, H. M. Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci. Res. Commun. 7:113-122; 1990.
16. Lehtimäki, T.; Moilanen, T.; Viikari, J.; Akerblom, H. K.; Ehnholm, C.; Rönnemaa, T.; Marniemi, J.; Dahlen, G.; Nikkari, T. Apolipoprotein E phenotypes in Finnish youths; A cross-sectional and six-year follow-up study. J. Lipid Res. 31:487-495; 1990.
17. Lehtimäki, T.; Pirttilä, T.; Mehta, P. D.; Wisniewski, H. M.; Frey, H.; Nikkari, T. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum. Genet. 95:39-42; 1995.
18. Lorenzo, A.; Yankner, B. A. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red. Proc. Natl. Acad. Sci. USA 91:12243-12247; 1994.
19. Maniatis, T.; Fritsch, E. F.; Sambrook, J. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1982.
20. Mann, D. M. A.; Pickering-Brown, S. M.; Siddons, M. A.; Iwatsubo, T.; Ihara, Y.; Asami-Odaka, A.; Suzuki, N. The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype. Neurosci. Lett. 196:105-108; 1995.
21. McKee, A.C.; Kosik, K. S.; Kowall, N. W. Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30:156-165; 1991.
22. McKhann, G.; Drachman, D.; Folstein, M.; Katzman, R.; Price, D.; Stadlan, E. M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944; 1984.
23. Mehta, P. D.; Kim, K. S.; Wisniewski, H. M. ELISA as a laboratory-test to aid the diagnosis of Alzheimer's disease. Tech. Diagnos. Pathol. 2:99-112; 1991.
24. Mehta, P. D.; Miller, J. A.; Tourtellotte, W. W. Oligoclonal IgG bands in plaques from multiple sclerosis brains. Neurology 32:372-376; 1982.
25. Mirra, S.S.; Heyman, A.; McKeel, D.; Sumi, S. M.; Crain, B. J.; Brownlee, L. M.; Vogel, F. S.; Hughes, J. P.; van Belle, G.; Berg, L.; and participating CERAD neuropathologists. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486; 1991.
26. Nagy, Z. S.; Esiri, M. M.; Jobst, K. A.; Johnston, C.; Litchfield, S.; Sim, E.; Smith, A. D. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 69:757-761; 1995.
27. Pike, C. J.; Burdick, D.; Walencewicz, A. J.; Glabe, C. G.; Cotman, C. W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1676-1687; 1993.
28. Pirttilä, T.; Kim, K. S.; Mehta, P. D.; Frey, H.; Wisniewski, H. M. Soluble amyloid β-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls. J. Neurol. Sci. 127:90-95; 1994.
29. Poirier, J.; Davignon, J.; Bouthillier, D.; Kogan, S.; Bertrand, P.; Gauthier, S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699; 1993.
30. Polvikoski, T.; Sulkava, R.; Haltia, M.; Kainulainen, K.; Vuorio, A.; Verkkoniemi, A.; Niinistö, L.; Halonen, P.; Kontula, K. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N. Engl. J. Med. 333:1242-1247; 1995.
31. Rebeck, G. W.; Reiter, J. S.; Strickland, D. K.; Hyman, B. T. Apolipoprotein E in sporadic Alzheimer's disease: Allele variation and receptor interactions. Neuron 11:575-580; 1993.
32. Roberts, G. W.; Gentleman, S. M.; Lynch, A.; Graham, D.I. βA4 amyloid protein deposition in the brain after head trauma. Lancet 338:1422-1423; 1991.
33. Samuel, W.; Terry, R. D.; DeTeresa, R.; Butters, N.; Masliah, E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch. Neurol. 51:772-778; 1994.
34. Saunders, A. M.; Strittmatter, W. J.; Schmechel, D.; St. George-Hyslop, P. H.; Pericak-Vance, M. A.; Joo, S. H.; Rosi, B. L.; Gusella, J. F.; Crapper-MacLachlan, D. R.; Alberts, M. J.; Hulette, C.; Grain, B.; Goldgaber, D.; Roses, A. D. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472; 1993.
35. Schmechel, D. E.; Saunders, A. M.; Strittmatter, W. J.; Crain, B. J.; Hulette, C. M.; Joo, S. H.; Pericak-Vance, M. A.; Goldgaber, D.; Roses, A. D. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:9649-9653; 1993.
36. Selkoe, D. Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17:489-517; 1994.
37. Seubert, P.; Vigo-Pelfrey, C.; Esch, F.; Lee, M.; Dovey, H.; Davis, D.; Sinha, S.; Schlossmacher, M.; Whaley, J.; Swindlehurst, C.; McCormack, R.; Wolfert, R.; Selkoe, D.; Lieberburg, I.; Schenk, D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327; 1992.
38. Spillantini, M. G.; Goedert, M.; Jakes, R.; Klug, A. Different configurational stress of β-amyloid and their distributions relative to plaques and tangles in Alzheimer disease. Proc. Natl. Acad. Sci. USA 87: 3947-3951; 1990.
39. Strittmatter, W. J.; Weisgraber, K. H.; Goedert, M.; Saunders, A. M.; Huang, D.; Coder, E. H.; Dong, L. M.; Jakes, R.; Alberts, M. J.; Gil-bert, J. R.; Han, S. H.; Hulette, C.; Einstein, G.; Schmechel, D. E.; Pericak-Vance, M. A.; Roses, A. D. Hypothesis-Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol. 125:163-171; 1994.
40. Suzuki, N.; Iwatsubo, T.; Odaka, A.; Ishibashi, Y.; Kitada, C.; Ihara, Y. High tissue content of soluble βl-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 145:452-160; 1994.
41. Tabaton, M.; Gracia Nunzi, M.; Xue, R.; Usiak, M.; Autilio-Gambetti, L.; Gambetti, P. Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem. Biophys. Res. Commun. 200:1598-1603; 1994.
42. Tamaoka, A.; Kondo, T.; Odaka, A.; Sahara, N.; Sawamura, N.; Ozawa, K.; Suzuki, N.; Shoji, S.; Mori, H. Biochemical evidence for the long-tail form (Aβl-42/43) of amyloid βprotein as a seed molecule in cerebral deposits of Alzheimer's disease. Biochem. Biophys. Res. Commun. 205:834-842; 1994.
43. Tamaoka, A.; Sawamura, N.; Odaka, A.; Suzuki, N.; Mizusawa, H.; Shoji, S.; Mori, H. Amyloid β protein 1-42/43 (Aβl-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study. Brain Res. 679:151-156; 1995.
44. Tsukamoto, K.; Watanabe, T.; Matsushima, T.; Kinoshita, M.; Kalo, H.; Hashimoto, Y.; Kurokawa, K.; Teramoto, T. Determination by PCR-RFLP of apoE genotype in a Japanese population. J. Lab. Clin. Med. 121:598-602; 1993.
45. Vandenplas, S.; Grobler-Rabie, A.; Brebner, K.; Ricketts, M.; Wallis, G.; Bester, A.; Boyd, C.; Matthew, C. Blot hybridization of genomic DNA. J. Med. Genet. 21:164-172; 1984.
46. Wisniewski, H. M.; Wegiel, J. The neuropathology of Alzheimer's disease. Neuroimag. Clin. North Am. 5:45-57; 1995.
47. Yamaguchi, H.; Sugihara, S.; Ishiguro, K.; Takashima, A.; Hirai, S. Immunohistochemical analysis of COOH-terminal of amyloid beta protein (Aβ) using end-specific antisera for Aβ40 and Aβ42 in Alzheimer's disease and normal aging. Amyloid Int. J. Exp. Clin. Invest. 2:7-16; 1995.